Indegene quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	1,122	804	+39.6%
EBITDA	186	141	+32.1%
EBITDA margin	16.6%	17.5%	−0.9 pts
Profit before tax	147	133	+10.7%
Net profit	112	102	+10.0%
EPS	₹4.67	₹4.26	+9.6%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024

Expenses
	1,122	1,063	1,003	942	804	761	756	720	687	677	673
	15.0	29.0	10.8	19.4	19.7	22.1	25.6	37.7	21.4	22.5	23.2
	1,137	1,092	1,014	962	824	783	781	758	708	699	696
	682	659	632	568	516	482	485	444	442	444	428
	6.9	6.4	7.2	4.6	3.8	3.7	3.1	3.2	4.0	11.7	12.3
	46.4	44.1	41.8	39.6	23.4	21.6	20.7	20.0	19.4	20.1	18.5
	255	230	207	215	148	124	123	145	119	103	106
	990	939	889	827	691	631	632	612	584	579	565
	186	174	164	160	141	155	148	132	126	129	139
	139	130	122	120	117	134	127	112	107	109	120
Profit
	147	153	125	135	133	152	149	146	124	120	131
	0.0	0.0	−20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4
	147	153	105	135	133	152	149	146	124	120	134
	41.1	29.3	22.6	87.4	37.9	28.4	43.8	33.8	36.3	35.2	13.1
	−6.0	7.2	2.8	−55.6	−6.9	7.3	−12.1	2.8	−3.9	−3.3	25.6
	35.1	36.5	25.4	31.8	31.0	35.7	31.7	36.6	32.4	31.9	38.7
	112	116	79.7	103	102	116	118	110	91.7	87.7	94.8
	112	116	79.7	103	102	116	118	110	91.7	87.7	94.8
	21.0	11.8	55.0	19.3	48.4	16.7	2.6	13.2	10.6	−0.8	1.8
	133	128	135	122	151	133	120	123	102	86.9	96.6
	112	116	79.7	103	102	116	—	110	91.7	87.7	96.6
Per share
	₹4.67	₹4.84	₹3.32	₹4.29	₹4.26	₹4.86	₹4.91	₹4.59	₹3.84	₹3.79	₹4.27
	₹4.64	₹4.81	₹3.30	₹4.26	₹4.23	₹4.82	₹4.88	₹4.55	₹3.80	₹3.76	₹4.24
Other comprehensive income — detail
	21.0	11.8	55.0	19.3	48.4	16.7	2.6	—	—	—	—
	5.2	−2.9	−0.1	0.6	2.4	1.2	−3.9	1.1	−0.8	1.5	−0.2
	1.3	−0.7	−0.1	0.2	0.6	0.3	−1.0	—	—	—	—
	—	—	—	—	—	—	—	0.3	−0.2	0.4	−0.1
	15.5	15.5	53.3	18.9	46.6	15.8	5.5	12.4	11.2	−1.9	1.9
	−1.6	1.5	−1.7	0.0	0.0	0.0	0.0	—	—	—	—
	21.0	128	135	122	—	—	120	123	102	86.9	—
Per share — as-filed variants
	₹4.67	₹4.84	₹3.32	₹4.29	₹4.26	₹4.86	₹4.91	₹4.59	₹3.84	₹3.79	₹4.27
	₹4.64	₹4.81	₹3.30	₹4.26	₹4.23	₹4.82	₹4.88	₹4.55	₹3.80	₹3.76	₹4.24
Adjusted (ex-exceptional items) — derived
	147	153	125	135	133	152	149	146	124	120	131
	0.0	0.0	−20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4
	112	116	95.1	103	102	116	118	110	91.7	87.7	93.1
	₹4.67	₹4.84	₹3.96	₹4.29	₹4.26	₹4.86	₹4.91	₹4.59	₹3.84	₹3.79	₹4.19

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INDGN₹593.45

Indegene Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersSYNGENE LTTS GRANULES JUBLPHARMA KIMS ERIS EMCURE ONESOURCEMcap ₹14,272 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	673.0	676.5	686.8	720.4	755.6	760.8	804.2	942.1	1,003.4	1,063.1	1,122.3
Other Income	23.2	22.5	21.4	37.7	25.6	22.1	19.7	19.4	10.8	29.0	15.0
Total Income	696.2	699.0	708.2	758.1	781.2	782.9	823.9	961.5	1,014.2	1,092.1	1,137.3
Expenses
+ Employee Benefit Expense	428.4	444.3	442.0	443.8	485.1	481.5	515.8	568.0	632.4	659.1	681.7
+ Finance Costs	12.3	11.7	4.0	3.2	3.1	3.7	3.8	4.6	7.2	6.4	6.9
+ Depreciation & Amortisation	18.5	20.1	19.4	20.0	20.7	21.6	23.4	39.6	41.8	44.1	46.4
+ Other Expenses	105.9	103.3	118.7	144.8	123.0	124.0	147.8	214.6	207.4	229.8	254.9
Total Expenses	565.1	579.4	584.1	611.8	631.9	630.8	690.8	826.8	888.8	939.4	989.9
EBITDA	138.7	128.9	126.1	131.8	147.5	155.3	140.6	159.5	163.6	174.2	185.7
EBIT	120.2	108.8	106.7	111.8	126.8	133.7	117.2	119.9	121.8	130.1	139.3
Profit
PBT before Exceptional Items	131.1	119.6	124.1	146.3	149.3	152.1	133.1	134.7	125.4	152.7	147.4
+ Exceptional Items	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-20.3	0.0	0.0
Pretax Income	133.5	119.6	124.1	146.3	149.3	152.1	133.1	134.7	105.1	152.7	147.4
+ Current Tax	13.1	35.2	36.3	33.8	43.8	28.4	37.9	87.4	22.6	29.3	41.1
+ Deferred Tax	25.6	-3.3	-3.9	2.8	-12.1	7.3	-6.9	-55.6	2.8	7.2	-6.0
Tax Expense	38.7	31.9	32.4	36.6	31.7	35.7	31.0	31.8	25.4	36.5	35.1
Net Income	94.8	87.7	91.7	109.7	117.6	116.4	102.1	102.9	79.7	116.2	112.3
+ Net Income — Continuing Ops	94.8	87.7	91.7	109.7	117.6	116.4	102.1	102.9	79.7	116.2	112.3
+ Other Comprehensive Income	1.8	-0.8	10.6	13.2	2.6	16.7	48.4	19.3	55.0	11.8	21.0
Total Comprehensive Income	96.6	86.9	102.3	122.9	120.2	133.1	150.5	122.2	134.7	128.0	133.3
Net Income to Common	96.6	87.7	91.7	109.7	—	116.4	102.1	102.9	79.7	116.2	112.3
Per Share
Basic EPS	4.27	3.79	3.84	4.59	4.91	4.86	4.26	4.29	3.32	4.84	4.67
Diluted EPS	4.24	3.76	3.80	4.55	4.88	4.82	4.23	4.26	3.30	4.81	4.64
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	2.6	16.7	48.4	19.3	55.0	11.8	21.0
+ Items NOT to be Reclassified to P&L	-0.2	1.5	-0.8	1.1	-3.9	1.2	2.4	0.6	-0.1	-2.9	5.2
+ Tax on Items NOT to be Reclassified	—	—	—	—	-1.0	0.3	0.6	0.2	-0.1	-0.7	1.3
+ Tax on Items NOT to be Reclassified — alt tag	-0.1	0.4	-0.2	0.3	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	1.9	-1.9	11.2	12.4	5.5	15.8	46.6	18.9	53.3	15.5	15.5
+ Tax on Items to be Reclassified	—	—	—	—	0.0	0.0	0.0	0.0	-1.7	1.5	-1.6
Comprehensive Income — Owners of Parent	—	86.9	102.3	122.9	120.2	—	—	122.2	134.7	128.0	21.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	4.27	3.79	3.84	4.59	4.91	4.86	4.26	4.29	3.32	4.84	4.67
Diluted EPS — Continuing Operations	4.24	3.76	3.80	4.55	4.88	4.82	4.23	4.26	3.30	4.81	4.64
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	131.1	119.6	124.1	146.3	149.3	152.1	133.1	134.7	125.4	152.7	147.4
− Exceptional Items (reconciliation)	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-20.3	0.0	0.0
Net Income Adj (tax-effected)	93.1	87.7	91.7	109.7	117.6	116.4	102.1	102.9	95.1	116.2	112.3
EPS Adj	4.19	3.79	3.84	4.59	4.91	4.86	4.26	4.29	3.96	4.84	4.67
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	44.4	47.9	47.8	47.8	47.9	47.9	48.0	48.0	48.1	48.1	48.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Indegene Q2 FY27 results (July–September 2026)

Filed with NSE on Thursday, 29 October 2026 at 7:40 pm IST

Indegene (NSE: INDGN) reported its Q2 FY27 results (July–September 2026) on Thursday, 29 October 2026 at 7:40 pm IST. Consolidated net profit was ₹112 crore, up 10.0% from ₹102 crore in Q2 FY26 and down 3.4% from ₹116 crore in Q1 FY27. Revenue from operations was ₹1,122 crore, up 39.6% year on year and up 5.6% from the previous quarter.

Q2 FY26 results (a year earlier): 30 October 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹112 Cr+10.0% vs Q2 FY26−3.4% vs Q1 FY27
Revenue from operations: ₹1,122 Cr+39.6% vs Q2 FY26+5.6% vs Q1 FY27
Operating margin (EBIT): 12.4%−2.2 pts vs Q2 FY26+0.2 pts vs Q1 FY27EBIT ₹139 Cr
EBITDA: ₹186 Cr+32.1% vs Q2 FY26+6.6% vs Q1 FY27margin 16.5%
Earnings per share (basic): ₹4.67+9.6% vs Q2 FY26−3.5% vs Q1 FY27
Net profit margin: 10.0%−2.7 pts vs Q2 FY26−0.9 pts vs Q1 FY27

Questions

What was Indegene's net profit in Q2 FY27?

Consolidated net profit was ₹112 crore, up 10.0% from ₹102 crore in Q2 FY26 and down 3.4% from ₹116 crore in Q1 FY27.

What was Indegene's revenue in Q2 FY27?

Revenue from operations was ₹1,122 crore, up 39.6% year on year and up 5.6% from the previous quarter.

What was Indegene's net profit in FY26?

Consolidated net profit was ₹401 crore in FY26 (April 2025–March 2026), down 1.4% from ₹407 crore in FY25. It was ₹345 crore in FY24.

How were Indegene's Q2 FY27 results?

Both grew from a year earlier: net profit was up 10.0% at ₹112 crore and revenue was up 39.6% at ₹1,122 crore. The operating margin was 12.4%, down 2.2 percentage points from 14.6% a year earlier. Against Q1 FY27, net profit was down 3.4% and revenue up 5.6%.

What was Indegene's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹139 crore, a margin of 12.4%, against 12.2% in Q1 FY27 and 14.6% in Q2 FY26. EBITDA was ₹186 crore, 16.5% of revenue.

What was Indegene's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹229 crore, up 4.6% from ₹219 crore in the same months a year earlier. Revenue from operations was ₹2,185 crore, up 39.6%.

What was Indegene's EPS in Q2 FY27?

Basic earnings per share were ₹4.67, against ₹4.26 in Q2 FY26.

What is Indegene's net profit margin?

Indegene's net profit margin was 10.0% in Q2 FY27 (net profit as a share of revenue from operations), against 12.7% in Q2 FY26 (down 2.7 percentage points). For FY26 as a whole it was 11.4%.

What was Indegene's revenue in FY26?

Revenue from operations was ₹3,511 crore in FY26 (April 2025–March 2026), up 23.6% from ₹2,839 crore in FY25. It was ₹2,590 crore in FY24.

How has Indegene's profit changed over the last four quarters?

Net profit by quarter: ₹103 crore in Q3 FY26, ₹79.7 crore in Q4 FY26, ₹116 crore in Q1 FY27 and ₹112 crore in Q2 FY27. That is ₹411 crore over the four quarters, down 7.8% from ₹446 crore in the four quarters before. Revenue from operations: ₹942 crore, ₹1,003 crore, ₹1,063 crore and ₹1,122 crore.

When did Indegene announce its Q2 FY27 results?

On Thursday, 29 October 2026 at 7:40 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 30 October 2025.

When will Indegene announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Indegene figures come from?

From Indegene's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 29 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.